share_log

Leerink Partners Upgrades WAVE Life Sciences to Outperform, Announces $12 Price Target

Benzinga ·  Dec 19, 2023 07:00

Leerink Partners analyst Mani Foroohar upgrades WAVE Life Sciences (NASDAQ:WVE) from Market Perform to Outperform and announces $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment